GlassScriptPhysician profile
Wesley A Peace
NPI 1932594702
$8,900.11
in general payments reported to CMS, 2019-2025
27 companies · $1,513 in 2025
The $1,513 reported for 2025 was more than what 91% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $313 · 2021: $742 · 2022: $1,899 · 2023: $1,361 · 2024: $2,901 · 2025: $1,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,775.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,713.24 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $1,717.36 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Nevro Corp. | $388.82 | 2021-2024 | Senza |
| Spr Therapeutics, INC | $238.27 | 2022-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $154.69 | 2020-2023 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $90.82 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.66 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $62.51 | 2023 | Dysport |
| Curonix LLC | $60.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $43.98 | 2024 | |
| Scilex Pharmaceuticals INC. | $40.55 | 2022 | |
| Lilly USA, LLC | $32.96 | 2021 | |
| Pfizer INC. | $30.48 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $28.01 | 2024 | |
| Pacira Therapeutics, INC. | $26.99 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $24.79 | 2025 | Evoke |
| Nalu Medical, INC. | $22.89 | 2021 | |
| Medtronic, INC. | $21.00 | 2022 | |
| Stimwave Technologies Incorporated | $19.53 | 2020 | |
| Protega Pharmaceutials INC | $18.53 | 2025 | Roxybond |
| Kowa Pharmaceuticals America, INC. | $16.24 | 2022 | |
| Virtus Pharmaceuticals LLC | $13.91 | 2020 | |
| Radius Health, INC. | $12.72 | 2020 | |
| Siemens Medical Solutions USA, INC. | $11.94 | 2021 | |
| Ibsa Pharma INC. | $11.25 | 2021 | |
| Zyla Life Sciences, INC. | $11.13 | 2020 | |
| Kinex Medical Company LLC | $2.81 | 2024 | Kinex Kck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Peace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.